Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 8 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0 trials in Phase 3/4

Results Transparency

38%

3 of 8 completed trials have results

Key Signals

3 with results

Enrollment Performance

Analytics

N/A

4(66.7%)

Early Phase 1

2(33.3%)

6Total

N/A(4)

Early Phase 1(2)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (8)

Showing 8 of 8 trials

NCT01876524Not ApplicableCompleted

tRNS in Anterior Cingulate Cortex Reduces Craving Over Dual Pathology Patients

Role: lead

NCT02004236Not ApplicableCompleted

Fronto-temporal tDCS Mproves Fluency & Empathy in ASD Kids

Role: lead

NCT01649232Completed

ADHD Electrophysiological Subtypes and Implications in Transcranial Direct-current Stimulation

Role: lead

NCT05825274Not ApplicableCompleted

TDCs to Treat Drug-resistant Epilepsy

Role: lead

NCT01856686Early Phase 1Completed

Neurocognitive and Neurobiological Improvement in ADHD Children by Modification of Dietary Protein

Role: lead

NCT02656433Not ApplicableCompleted

tES With Random Noise Stimulation Applied to Children With Brain Injury

Role: lead

NCT02662270Completed

QEEG and Qualitative EEG for the Identidification of Abnormal Patterns in Fibromyalgia Patients

Role: lead

NCT02614599Early Phase 1Completed

Neurocognitive and Neurobiological Improvement in ADHD Children With High Protein Diet

Role: lead

All 8 trials loaded